Brittany Avin McKelvey, Senior Director of Regulatory Policy at LUNGevity Foundation, shared on LinkedIn:
“LUNGevity Foundation Transforming Clinical Trials Initiative (TCTI) Q2 newsletter is out today!
We’ve been busy this past quarter:
- Presenting at and Attending Several International Conferences
- Submitting Comments to FDA and EMA
- Discussing Covariate Adjustment in Oncology Clinical Trials: Project SignifiCanT
- Providing Learnings from the April ODAC Meeting
- Supporting FDA and Clinical Trial Reform: PDUFA VIII and Related Legislation
Not on our mailing list? Feel free to reach out to stay up to date!”
Other articles about LUNGevity Foundation on OncoDaily.